66938 Federal Register / Vol. 66, No. 248 / Thursday, December 27, 2001 / Notices

information should address one or more

of the following four points:

(1) Evaluate whether the proposed

collection of information is necessary

for the proper performance of the

function of the agency, including

whether the information will have

practical utility;

(2) Evaluate the accuracy of the

agency’s estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used;

(3) Enhance the quality, utility, and

clarity of the information to be

collected; and

(4) Minimize the burden of the

collection of information on those who

are to respond, including through the

use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology,

e.g., permitting electronic submission of

responses.

Overview of This Information

Collection

(1) Type of information collection:

Extension of a currently approved

collection.

(2) The title of the form/collection:

ARCOS Transaction Reporting—DEA

Form 333.

The agency form number, if any, and

the applicable component of the

Department sponsoring the collection:

Form No.: DEA–333. Office of Diversion

Control, Drug Enforcement

Administration, U.S. Department of

Justice.

(4) Affected public who will be asked

or required to respond, as well as a brief

abstract: Primary: Business or other forprofit. Other: None.

Necessary for U.S. to meet obligations

under two international treaties: Single

Convention on Narcotic Drugs and

Psychotropic Substances. Treaties

require information on the manufacture

and consumption of certain substances.

Information tracks substances from

manufactured to sale to dispensing

level.

(5) An estimate of the total number of

respondents and the amount of time

estimated for an average respondent to

respond/reply: 1,126 respondents with

an average 1 hour per paper response

and 10 minutes per electronic response.

(6) An estimate of the total public

burden (in hours) associated with the

collection: 1,700 annual burden hours.

If additional information is required

contact: Mr. Robert B. Briggs, Clearance

Officer, United States Department of

Justice, Information Management and

Security Staff, Justice Management

Division, United States Department of

Justice, Patrick Henry Building, Suite

1600, 601 D Street NW, Washington, DC

20004.

Dated: December 18, 2001.

Robert B. Briggs,

Department Clearance Officer, United States

Department of Justice.

[FR Doc. 01–31679 Filed 12–26–01; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Agency Information Collection

Activities: Proposed Collection;

Comment Request

ACTION: 30-day notice of information

collection under review: extension of a

currently approved collection; U.S.

official order forms for Schedules I and

II controlled substances

(ACCOUNTABLE FORMS), order form

requisition.

The Department of Justice (DOJ), Drug

Enforcement Administration (DEA), has

submitted the following information

collection request to the Office of

Management and Budget (OMB) for

review and approval in accordance with

the Paperwork Reduction Act of 1995.

The proposed information collection is

published to obtain comments from the

public and affected agencies. This

proposed information collection was

previously published in the Federal

Register Volume 66, Number 201, pages

52778–52779 on October 17, 2001,

allowing for a 60-day comment period.

The purpose of this notice is to allow

for an additional 30 days for public

comment until January 28, 2002. This

process is conducted in accordance with

5 CFR 1320.10.

Written comments and/or suggestions

regarding the items contained in this

notice, especially the estimated public

burden and associated response time,

should be directed to The Office of

Management and Budget, Office of

Information and Regulatory Affairs,

Attention Department of Justice Desk

Officer, Washington, DC 20503.

Additionally, comments may be

submitted to OMB via facsimile to

(202)–395–7285.

Written comments and/or suggestions

from the public and affected agencies

concerning the proposed collection of

information should address one or more

of the following four points:

(1) Evaluate whether the proposed

collection of information is necessary

for the proper performance of the

function of the agency, including

whether the information will have

practical utility;

(2) Evaluate the accuracy of the

agency’s estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used;

(3) Enhance the quality, utility, and

clarity of the information to be

collected; and

(4) Minimize the burden of the

collection of information on those who

are to respond, including through the

use of appropriated automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology,

e.g., permitting electronic submission of

responses.

Overview of This Information

Collection

(1) Type of information collection:

Extension of a currently approved

collection.

(2) The title of the form/collection:

U.S. Official Order Forms for Schedules

I and II Controlled Substances

(ACCOUNTABLE FORMS), Order Form

Requisition.

(3) The agency form number, if any,

and the applicable component of the

Department sponsoring the collection:

Form No.: DEA Form 222 and DEA

Form 222a Office of Diversion Control,

Drug Enforcement Administration, U.S.

Department of Justice.

(4) Affected public who will be asked

or required to respond, as well as brief

abstract: Primary: Business or other forprofit. Other: Individuals or households,

Federal Government, and State, Local or

Tribal Government. DEA–222 is used to

transfer or purchase Schedule I and II

controlled substances and data is

needed to provide an audit of transfer

and purchase. DEA–222a Requisition

Form is used to obtain the DEA–222

Order Form. Respondents are DEA

registrants desiring to handle these

controlled substances.

(5) An estimate of the total number of

respondents and the amount of time

estimated for an average respondents to

respond/reply: 89,908 respondents with

an average 17.5 minutes per response.

(6) An estimate of the total public

burden (in hours) associated with the

collection: 193,508 annual burden

hours.

If additional information is required

contact: Mr. Robert B. Briggs, Clearance

Officer, United States Department of

Justice, Information Management and

Security Staff, Justice Management

Division, United States Department of

Justice, Patrick Henry Building, Suite

1600, 601 D Street NE, Washington, DC

20004.

Federal Register / Vol. 66, No. 248 / Thursday, December 27, 2001 / Notices 66939

Dated: December 18, 2001.

Robert B. Briggs,

Department Clearance Officer, United States

Department of Justice.

[FR Doc. 01–31680 Filed 12–26–01; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Application

Pursuant to section 1301.33(a) of Title

21 of the Code of Federal Regulations

(CFR), this is notice that on September

27, 2001, Chattem Chemicals, Inc., 3801

St. Elmo Avenue, Building 18,

Chattanooga, Tennessee 37409, made

application by letter to the Drug

Enforcement Administration (DEA) for

registration as a bulk manufacturer of

dextropropoxyphene (9273), a basic

class of controlled substance listed in

Schedule II.

The firm plans to bulk manufacture

the listed controlled substance to

produce products for distribution to its

customers.

Any other such applicant and any

person who is presently registered with

DEA to manufacture such substance

may file comments or objections to the

issuance of the proposed registration.

Any such comments or objections

may be addressed, in quintuplicate, to

the Deputy Assistant Administration,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, DC 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than February

25, 2002.

Dated: December 18, 2001.

Laura M. Nagel,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 01–31821 Filed 12–26–01; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated August 24, 2001, and

published in the Federal Register on

September 6, 2001, (66 FR 46653),

Chattem Chemicals, Inc., 3801 St. Elmo

Avenue, Building 18, Chattanooga,

Tennessee 37409, made application by

renewal to the Drug Enforcement

Administration (DEA) to be registered as

a bulk manufacturer of the basic classes

of controlled substances listed below:

Drug Schedule

N-Ethylamphetamine (1475) I

4-Methoxyamphetamine

(7411).

I

2,5-Dimethoxyamphetamine

(7396).

I

Difenoxin ............................... I

Amphetamine (1100) ............ II

Methamphetamine (1105) ..... II

Methylphenidate (1724) ........ II

Pentobarbital (2270) ............. II

Secobarbital (2315) .............. II

Codeine (9050) ..................... II

Oxycodone (9143) ................ II

Diphenoxylate (9170) ............ II

Hydrocodone (9193) ............. II

Meperidine (9230) ................. II

Morphine (9300) ................... II

Thebaine (9333) ................... II

Alfentanil (9737) .................... II

Sufentanil (9740) .................. II

Fentanyl (9801) ..................... II

The firm plans to bulk manufacture

the listed controlled substances to

produce products for distribution to its

customers.

No comments or objections have been

received. DEA has considered the

factors in Title 21, United States Code,

Section 823(a) and determined that the

registration of Chattem Chemicals, Inc.

to manufacture the listed controlled

substances is consistent with the public

interest at this time. DEA has

investigated Chattem Chemicals, Inc. to

ensure that the company’s registration is

consistent with the public interest. This

investigation included inspection and

testing of the company’s physical

security systems, verification of the

company’s compliance with state and

local laws, and a review of the

company’s background and history.

Therefore, pursuant to 21 U.S.C. 823

and 28 CFR §§ 0.100 and 0.104, the

Deputy Assistant Administrator, Office

of Diversion Control, hereby orders that

the application submitted by the above

firm for registration as a bulk

manufacturer of the basic classes of

controlled substances listed above is

granted.

Dated: December 18, 2001.

Laura M. Nagel,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 01–31822 Filed 12–26–01; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF LABOR

Office of the Secretary

Submission for OMB Review;

Comment Request

December 13, 2001.

The Department of Labor (DOL) has

submitted the following public

information collection requests (ICRs) to

the Office of Management and Budget

(OMB) for review and approval in

accordance with the Paperwork

Reduction Act of 1995 (Pub. L. 104–13,

44 U.S.C. Chapter 35). A copy of this

ICR, with applicable supporting

documentation, may be obtained by

calling the Department of Labor. To

obtain documentation contact Darrin

King on (202) 693–4129 or E-Mail: KingDarrin@dol.gov.

Comments should be sent to Office of

Information and Regulatory Affairs,

Attn: OMB Desk Officer for OSHA,

Office of Management and Budget,

Room 10235, Washington, DC 20503

(202) 395–7316), within 30 days from

the date of this publication in the

Federal Register.

The OMB is particularly interested in

comments which:

• Evaluate whether the proposed

collection of information is unnecessary

for the proper performance of the

functions of the agency, including

whether the information will have

practical utility.

• Evaluate the accuracy of the

agency’s estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used:

• Enhance the quality, utility, and

clarity of the information to be

collected; and

• Minimize the burden of the

collection of information on those who

are to respond, including through the

use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology,

e.g., permitting electronic submission of

responses.

Type of Review: Existing collection

without an OMB control number.

Agency: Occupational Safety and

Health Administration (OSHA).

Title: Occupational Safety and Health

State Plan Information.

OMB Number: 1218–ONEW.

Affected Public: State, Local, or Tribal

Government.

Frequency: On occasion, Quarterly,

and Annually.

Type of Response: Reporting.

Number of Respondents: 26.

Number of Annual Responses: 1,552.